We report the case of a patient with type 2 diabetes and severe obesity who had an excellent therapeutic response to diet control with lifestyle modifications and GLP-1 receptor agonists, which included significant improvements in weight and glycemic control. This evidence concerns the gene GLP1R and obesity disorder.